A COVID-19 vaccine for older adults -- one of our most vulnerable populations
A successful COVID-19 vaccine will need to protect those who are 65 or older, one of our most vulnerable populations.
New COVID-19 vaccines are flooding our feeds, but are any of them manufacturable at scale?
We’re bombarded every day with news about the latest miracle vaccine candidate: when it will be available, which vaccines have reached clinical trials, the stock market performance of the manufacturers, and so on.
The most powerful vaccine you haven’t heard about…
The race is on. Across the globe, researchers, scientists and CEOs are developing more than 160 vaccines, all taking aim at COVID-19.